Predictors of recurrence after durable pulmonary vein isolation for paroxysmal atrial fibrillation.
Michelle LyckeMaria KyriakopoulouMilad El HaddadJean-Yves WielandtsGabriela HilfikerAlexandre AlmoradVincenzo SchillaciJan De PooterMichael WolfPhilippe UngerYves VandekerckhoveRené TavernierJean-Benoît E Polain de WarouxMattias DuytschaeverSébastien KnechtPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2021)
The DAT is the most important predictor of arrhythmia recurrence in low-risk patients treated with durable pulmonary vein isolation for paroxysmal AF. Whether reducing the DAT could improve long-term outcomes should be investigated in another trial.
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial
- oral anticoagulants
- left atrial appendage
- direct oral anticoagulants
- heart failure
- study protocol
- clinical trial
- percutaneous coronary intervention
- phase iii
- phase ii
- randomized controlled trial
- free survival
- atomic force microscopy
- left ventricular
- open label
- double blind
- high speed